Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Seoul National University R & Db Foundation currently manages 3 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 3 distinct examiners, indicating a diverse range of reviews for the foundation's active patent applications. This distribution suggests that the foundation's research covers multiple specific sub-sectors within the broader biological and pharmaceutical fields, each subject to independent evaluation.
The prosecution activity is further divided across 3 distinct art units. This separation into different art units implies that the technological focus of the 3 pending office actions is distinct enough to require different departmental expertise within the patent office. BARBER, KIMBERLY is identified as the busiest examiner for the portfolio, currently managing 1 pending office action. This means that the workload is distributed, as no 1 examiner handles the majority of the active matters.
For a practitioner, the presence of 3 distinct examiners and 3 distinct art units requires a strategy that accounts for different examiner styles and departmental standards. While the total number of pending office actions is 3, the diversity in examiners and art units prevents a single point of failure. The fact that BARBER, KIMBERLY has 1 pending office action highlights that the foundation's Biotechnology & Pharmaceuticals portfolio is currently being evaluated through multiple independent channels.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BARBER, KIMBERLY | 1 | 72.6% | +19.7% |
| YOUNG, MICAH PAUL | 1 | 55.2% | +30.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18704561 | GENE DELIVERY COMPOSITION COMPRISING NITROGEN-DOPED GRAPHENE QUANTUM DOTS | BARBER, KIMBERLY | 17d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18704561 | GENE DELIVERY COMPOSITION COMPRISING NITROGEN-DOPED GRAPHENE QUANTUM DOTS | BARBER, KIMBERLY | 17d overdue |
| 18042806 | MRI CONTRAST MEDIUM INCLUDING CARBON-13-CONTAINING GRAPHENE QUANTUM DOT AND PREPARATION METHOD THEREFOR | YOUNG, MICAH PAUL | 15d |
| Art Unit | Apps |
|---|---|
| 1615 | 1 |
| 1618 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18704561 | GENE DELIVERY COMPOSITION COMPRISING NITROGEN-DOPED GRAPHENE QUANTUM DOTS | BARBER, KIMBERLY | 1615 | §103§112 | Final Rejection | 17d overdue | Pending | Apr 25, 2024 |
| 18042806 | MRI CONTRAST MEDIUM INCLUDING CARBON-13-CONTAINING GRAPHENE QUANTUM DOT AND PREPARATION METHOD THEREFOR | YOUNG, MICAH PAUL | 1618 | §103 | Non-Final OA | 15d | Pending | Feb 24, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSeoul National University R & Db Foundation has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Kimberly Barber has the most, with 1 of Seoul National University R & Db Foundation's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
